Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Romics

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
International Urology and Nephrology|January 1, 1982
The investigation of cellular and humoral immune reactivity in patients with tumours of the bladderI Romics, J Fehér, J Horváth, et al.
Zeitschrift Fur Urologie Und Nephrologie|January 1, 1983
[Clinical value of immunologic studies in patients with bladder tumors]I Romics, J Fehér, L Kisbenedek, et al.
Der Urologe. Ausg. A|September 1, 1983
[Cholesterol elimination in the urinary tract]I Romics, L Romics, L Szollár, et al.
Zeitschrift Fur Urologie Und Nephrologie|August 1, 1981
[Clinical and immunological studies in patients with prostatic tumors]I Romics, J Fehér, J Horváth, et al.
Acta Physiologica Hungarica|November 28, 2009
Ureteral motilityF Osman, I Romics, P Nyírády, et al.
Urologia Internationalis|December 11, 1999
Apoptosis, mitosis, p53, bcl(2), Ki-67 and clinical outcome in prostate carcinoma treated by androgen ablationB Szende, I Romics, I Torda, et al.
Orvosi Hetilap|June 18, 1995
[Flow cytometric examinations of patients after radical surgery for prostatic cancer]I Romics, J Bocsi, D Bach, et al.
Annales D'Urologie|September 20, 2000
Follow-up of prostate carcinoma patients treated with total androgen blockade by repeated map-biopsyJ Szabo, K Bartok, T Keréni, et al.
Anticancer Research|May 1, 1995
DNA content of prostatic cancer measured by flow cytometry in patients undergoing radical prostatectomyI Romics, J Bocsi, D Bach, et al.
Arzneimittel-Forschung|June 1, 1971
[Experimental liver lesions and its influencing by anorganic and organic magnesium salts]I Szelényi, E Nemesánszky, Z Nagy, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
International Urology and Nephrology|January 1, 1982
The investigation of cellular and humoral immune reactivity in patients with tumours of the bladderI Romics, J Fehér, J Horváth, et al.
Zeitschrift Fur Urologie Und Nephrologie|January 1, 1983
[Clinical value of immunologic studies in patients with bladder tumors]I Romics, J Fehér, L Kisbenedek, et al.
Der Urologe. Ausg. A|September 1, 1983
[Cholesterol elimination in the urinary tract]I Romics, L Romics, L Szollár, et al.
Zeitschrift Fur Urologie Und Nephrologie|August 1, 1981
[Clinical and immunological studies in patients with prostatic tumors]I Romics, J Fehér, J Horváth, et al.
Acta Physiologica Hungarica|November 28, 2009
Ureteral motilityF Osman, I Romics, P Nyírády, et al.
Urologia Internationalis|December 11, 1999
Apoptosis, mitosis, p53, bcl(2), Ki-67 and clinical outcome in prostate carcinoma treated by androgen ablationB Szende, I Romics, I Torda, et al.
Orvosi Hetilap|June 18, 1995
[Flow cytometric examinations of patients after radical surgery for prostatic cancer]I Romics, J Bocsi, D Bach, et al.
Annales D'Urologie|September 20, 2000
Follow-up of prostate carcinoma patients treated with total androgen blockade by repeated map-biopsyJ Szabo, K Bartok, T Keréni, et al.
Anticancer Research|May 1, 1995
DNA content of prostatic cancer measured by flow cytometry in patients undergoing radical prostatectomyI Romics, J Bocsi, D Bach, et al.
Arzneimittel-Forschung|June 1, 1971
[Experimental liver lesions and its influencing by anorganic and organic magnesium salts]I Szelényi, E Nemesánszky, Z Nagy, et al.
Pageof 8